What is the address of Medimax?

The registered office of Medimax is located at Caetsbeek 23, 3600 Genk.

Is Medimax still active?

Yes. According to the CBE (16 September 2026) Medimax is active, legal situation “Normale toestand”, started on 2 April 2009.

Is Medimax registered on Peppol?

Yes, Medimax is registered on the Peppol network with ID 0208:0810891591.

What is the enterprise number of Medimax?

The enterprise number of Medimax is BE0810891591.

When was Medimax founded?

Medimax was founded on 2 April 2009.

Who are the directors of Medimax?

According to the 2025 annual accounts, the directors of Medimax are: Christel Thomassen, Erik Maes.

Is Medimax a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 April 2009; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Medimax make in 2025?

Medimax posted a profit after taxes of € 41,124 in financial year 2025.

What is the revenue of Medimax?

As a small company, Medimax is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 79,789.

Medimax (Private Limited) - Genk - BE0810891591

Dossier Medimax, printed on 16 September 2026 from databakkes.be/en/0810891591/medimax. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Medimax from Genk, company number BE0810891591, closed financial year 2025 with a result of € 41,124 after tax. For that financial year Medimax recorded a gross margin of € 79,789 and equity of € 250,588. Compared with financial year 2024, the result moved from € 17,366 to € 41,124. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 13, 2026.

What it is worth Growing

€ 250,588

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 41,124

▲ 137% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 36,260

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 244,388.

People and assets in 2025

Wage cost

€ 1,152

▼ 56% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 18,822

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 15,096

▼ 51% vs 2024

€ 11,937 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 646

▼ 81% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 7,318

▲ 26% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 67,837 Gross margin 2022: € 67,837 First fiscal year in the series	€ 11,954 Gross margin 2023: € 11,954 ▼ 82% vs 2022 (€ 67,837) Unfavourable step	€ 43,689 Gross margin 2024: € 43,689 ▲ 265% vs 2023 (€ 11,954) Favourable step	€ 79,789 Gross margin 2025: € 79,789 ▲ 83% vs 2024 (€ 43,689) Favourable step	▲ 83%
Profit after taxes	€ 33,391 Profit after taxes 2022: € 33,391 First fiscal year in the series	€ -6,206 Profit after taxes 2023: € -6,206 ▼ € 39,597 vs 2022 (€ 33,391) Unfavourable step	€ 17,366 Profit after taxes 2024: € 17,366 ▲ € 23,572 vs 2023 (€ -6,206) Favourable step	€ 41,124 Profit after taxes 2025: € 41,124 ▲ 137% vs 2024 (€ 17,366) Favourable step	▲ 137%
Equity	€ 198,305 Equity 2022: € 198,305 First fiscal year in the series	€ 192,098 Equity 2023: € 192,098 ▼ 3% vs 2022 (€ 198,305) Unfavourable step	€ 209,464 Equity 2024: € 209,464 ▲ 9% vs 2023 (€ 192,098) Favourable step	€ 250,588 Equity 2025: € 250,588 ▲ 20% vs 2024 (€ 209,464) Favourable step	▲ 20%
Total debts	€ 82,523 Total debts 2022: € 82,523 First fiscal year in the series	€ 62,225 Total debts 2023: € 62,225 ▼ 25% vs 2022 (€ 82,523) Favourable step	€ 53,124 Total debts 2024: € 53,124 ▼ 15% vs 2023 (€ 62,225) Favourable step	€ 38,499 Total debts 2025: € 38,499 ▼ 28% vs 2024 (€ 53,124) Favourable step	▼ 28%
Cash	€ 142,081 Cash 2022: € 142,081 First fiscal year in the series	€ 16,727 Cash 2023: € 16,727 ▼ 88% vs 2022 (€ 142,081) Unfavourable step	€ 26,143 Cash 2024: € 26,143 ▲ 56% vs 2023 (€ 16,727) Favourable step	€ 36,260 Cash 2025: € 36,260 ▲ 39% vs 2024 (€ 26,143) Favourable step	▲ 39%
Retained profit	€ 192,105 Retained profit 2022: € 192,105 First fiscal year in the series	€ 185,898 Retained profit 2023: € 185,898 ▼ 3% vs 2022 (€ 192,105) Unfavourable step	€ 203,264 Retained profit 2024: € 203,264 ▲ 9% vs 2023 (€ 185,898) Favourable step	€ 244,388 Retained profit 2025: € 244,388 ▲ 20% vs 2024 (€ 203,264) Favourable step	▲ 20%
Bank debt	€ 38,666 Bank debt 2022: € 38,666 First fiscal year in the series	€ 28,793 Bank debt 2023: € 28,793 ▼ 26% vs 2022 (€ 38,666) Favourable step	€ 31,054 Bank debt 2024: € 31,054 ▲ 8% vs 2023 (€ 28,793) Unfavourable step	€ 15,096 Bank debt 2025: € 15,096 ▼ 51% vs 2024 (€ 31,054) Favourable step	▼ 51%
Balance sheet total	€ 280,828 Balance sheet total 2022: € 280,828 First fiscal year in the series	€ 254,323 Balance sheet total 2023: € 254,323 ▼ 9% vs 2022 (€ 280,828) Unchanged	€ 262,588 Balance sheet total 2024: € 262,588 ▲ 3% vs 2023 (€ 254,323) Unchanged	€ 289,087 Balance sheet total 2025: € 289,087 ▲ 10% vs 2024 (€ 262,588) Unchanged	▲ 10%

Key figures of Medimax, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Medimax?

What happened at Medimax in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 13, 2026 New annual accounts for financial year 2025: profit of € 41,124 (▲ 137% vs 2024). Source: NBB ↗
Apr 2, 2009 Start of the company according to the CBE. KBO

In short

From € 33,391 profit in 2022 to € 41,124 profit in 2025.

Paid € 47,917 in corporate taxes since 2022.

Best year ever: 2025, with € 41,124 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Medimax? We notify you, reason included.

Follow Medimax

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit